IP Library Assignment 048030/0489
Patent Assignment
Reel/Frame 048030/0489

Assignment of Assignor's Interest

Recorded: 2019-01-16 Pages: 8
Assignor
MELINTA THERAPEUTICS, INC.
Executed: 2017-11-03
Assignee
MELINTA SUBSIDIARY CORP.
300 GEORGE STREET, SUITE 301, NEW HAVEN, CONNECTICUT, 06511
Covered Properties (15)
Process for the Synthesis of Biaryl Oxazolidinones
Patent: 8,324,398 →
Application: 10/566,150 →
Publication: US 2010/0022772
Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
Patent: 6,969,726 →
Application: 10/859,476 →
Publication: US 2005/0043317
Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
Patent: 7,148,219 →
Application: 11/118,808 →
Publication: US 2005/0203147
Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
Patent: 7,456,206 →
Application: 11/486,769 →
Publication: US 2006/0264426
Process for the Synthesis of Triazoles
Patent: 8,399,660 →
Application: 11/921,838 →
Publication: US 2010/0234615
Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
Patent: 7,705,026 →
Application: 12/275,941 →
Publication: US 2009/0118502
Process for the Synthesis of Biaryl Oxazolidinones
Patent: 8,895,741 →
Application: 13/618,091 →
Publication: US 2013/0066076
Process for the Syntheses of Triazoles
Patent: 8,796,465 →
Application: 13/845,759 →
Publication: US 2014/0031402
Sustained Release Pharmaceutical Compositions Comprising an Antibacterial Agent
Patent: 9,409,896 →
Application: 13/882,698 →
Publication: US 2014/0094463
Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
Patent: 9,550,783 →
Application: 14/280,972 →
Publication: US 2015/0072970
Process for the Synthesis of Triazoles
Patent: 9,376,400 →
Application: 14/325,248 →
Publication: US 2015/0158827
Pharmaceutical Compositions of Oxazolidinone Antimicrobial Agents
Application: 14/630,584 →
Publication: US 2015/0165040
Method for Treating, Preventing, or Reducing the Risk of Skin Infection
Application: 14/942,021 →
Publication: US 2016/0136137
Pharmaceutical Compositions
Application: 15/260,424 →
Publication: US 2016/0374995
Topical Formulations of Biaryl Heterocyclic Compounds and Methods of Use Thereof
Application: 15/593,608 →
Publication: US 2017/0333400
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 20, 2012
From: WU, YUSHENG; CHEN, SHILI; CHEN, YI; HANSELMANN, ROGER
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 028993/0390 →
Change of Name Jan 7, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031934/0039 →
Change of Name Jan 10, 2014
From: RIB-X PHARAMCEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031969/0556 →
Change of Name Jan 10, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031969/0537 →
Change of Name Jan 13, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031997/0664 →
Change of Name Jan 13, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031997/0691 →
Change of Name Jan 13, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031997/0650 →
Assignment of Assignor's Interest Sep 24, 2014
From: ZHOU, JIACHENG; BHATTACHARJEE, ASHOKE; CHEN, SHILI; CHEN, YI
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 033811/0114 →
Assignment of Assignor's Interest Sep 24, 2014
From: SPRINGER, DANE M.
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 033811/0144 →
Change of Name Sep 24, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 033813/0633 →
Assignment of Assignor's Interest Dec 9, 2014
From: ZHOU, JIACHENG; BHATTACHARJEE, ASHOKE; CHEN, SHILI; CHEN, YI
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 034441/0193 →
Change of Name Dec 11, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 034596/0847 →
Assignment of Assignor's Interest Dec 7, 2015
From: DUFFY, ERIN M
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 037226/0932 →
Change of Name May 19, 2016
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 038754/0970 →
Assignment of Assignor's Interest May 19, 2016
From: CHEN, SHILI; LOU, ROBGLIANG; WU, YUSHENG; ZHOU, JIACHENG
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 038643/0448 →
Assignment of Assignor's Interest Jun 14, 2016
From: LI, DANPING; BURAK, ERIC S.
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 038904/0242 →
Change of Name Jun 14, 2016
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 038984/0332 →
Assignment of Assignor's Interest Nov 14, 2016
From: LI, DANPING
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 040312/0806 →
Change of Name Nov 18, 2016
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 040648/0438 →
Assignment of Assignor's Interest Sep 13, 2017
From: JOHNSON, KEITH ARTHUR; DUFFY, ERIN M.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 043578/0817 →
Security Interest Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Corrective Assignment to Correct the Assignor Previously Recorded on Reel 031969 Frame 0556. Assignor(S) Hereby Confirms the Change of Name. Jan 16, 2019
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 048078/0858 →
Intellectual Property Security Agreement Dec 22, 2020
From: MELINTA SUBSIDIARY CORP.
To: SILICON VALLEY BANK
Reel/Frame 054836/0824 →
Amended and Restated Intellectual Property Security Agreement Aug 25, 2022
From: MELINTA SUBSIDIARY CORP.
To: SILICON VALLEY BANK
Reel/Frame 061314/0572 →